Symbols
↓ ↑
Statistics Table
| Month | # Posts | # IMP | # ENG | Clicks | ER% | # Followers | # Podcast Plays | Podcast IMP | LI IMP | X IMP | FB IMP | IG IMP | LI ER% | X ER% | FB ER% | IG ER% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08 | 31 | 4100 | 514 | 11.69 | 728 | 19 | 3500 | 146 | 87 | 334 | 11.61 | 7.41 | 0.93 | 18.02 | ||
| 2023-09 | 44 | 6700 | 413 | 6.59 | 745 | 38 | 6309 | 151 | 74 | 154 | 6.05 | 5.41 | 0 | 15.37 | ||
| 2023-10 | 27 | 2100 | 143 | 8.64 | 771 | 56 | 1531 | 343 | 82 | 169 | 7.38 | 1.9 | 5.54 | 16.03 | ||
| 2023-11 | 66 | 7000 | 599 | - | 9.44 | 846 | 74 | - | 5900 | 605 | 100 | 268 | 8.12 | 5.52 | 1.98 | 26.52 |
| 2023-12 | 35 | 5000 | 360 | 141 | 5.5 | 862 | 110 | 279 | 4500 | - | 103 | 341 | 6.78 | - | 1.33 | 10 |
December 2023
Commentary
In total, we had 35 (↓31) posts across platforms in December. We did not publish content to X.
- Since our overall volume was down nearly 50%, our engagement rate across platforms was also cut nearly in half.
- New in December, we started tracking social clicks and attributed a theme/topic to all past and current social content. Our most engaging content by theme/topic in December was general HCP content (including this LinkedIn post comparing endometrial ablation methods) and posts about the company/leadership (including our holiday party, see below screenshot). YTD, the 3 most engaging topics/themes include conferences & congresses, HCP features & highlights, and company/leadership content.
- Total podcast plays were up 49% in December, driven by the Management of Menorrhagia and New Advances in Endometrial Ablation episodes which accounted for 75% of all podcast plays in December. We also began tracking podcast impressions, with our Hysterectomy After Endometrial Ablation episode receiving the most views.
- Since beginning our partnership with the BackTable OBGYN podcast in October, the Endometrial Ablation episode featuring Dr. Barbara Levy has received 390 podcast plays. In December there were 31 new plays of the episode.
Industry Highlights
On X, HCPs discuss birth control methods, including the IUD, and associated side effects including menorrhagia and dysmenorrhea. Another HCP discusses the role politics play in the treatment of heavy menstrual bleeding. A third HCP asks their audience to complete a survey on the use of tranexamic acid to decrease menorrhagia.
On Instagram, an HCP promotes the Mirena IUCD, stating that it can help reduce Menorrhagia.
In the media, a paper reviews new and emerging therapies for women, girls, and people with the potential to menstruate with von Willebrand disease (VWD).
Competitor Highlights
Hologic publishes a post on Instagram after the Massachusetts Conference for Women (260 likes) and also announces its upcoming participation at the 42nd Annual J.P. Morgan Healthcare Conference.
CooperSurgical hosts a roundtable with King’s Health Partners to discuss whether GLP1 Agonists spell the Rise or Demise of Metabolic Surgery.
October 2023
Commentary
In total, we had 27 (↓17) posts across platforms in October.
- While our post volume was down, engagement of our content increased on LinkedIn and Instagram (↑2% Engagement Rate).
- As we continue to diversify content formats and topics, our top content on Instagram included a Barbie as Gynecologist post for Halloween (30% ER) and a truth vs myth carousel (27% ER).
- Top LinkedIn content included our blog post on maintaining patient safety (9.4% ER) and a reshare of BackTable OBGYN’s podcast episode with Dr. Barbara Levy (8% ER). We continue to see a low amount of activation on Facebook.
- We added 18 new podcast plays in October, driven by the Management of Menorrhagia (+8) and New Advances in Endometrial Ablation with Cerene Cryotherapy (+4) episodes.
Industry Highlights
A study examines the impact of COVID-19 vaccinations on menstrual bleeding in 399 women in Saudi Arabia, with over half reporting abnormal menstrual bleeding after vaccination.
An informational article in The Medical Journal of Australia reports that HMB affections around 25% of Australian women but is often underdiagnosed and undertreated.
The AJMC reports that adolescents with sickle cell disease have a high prevalence of heavy menstrual bleeding and dysmenorrhea.
Competitor Highlights
Hologic partners with former Tennis champion Martina Navratilova and the WTA foundation to visit the NY Hope Lodge during Breast Cancer Awareness Month. The company also supports breast cancer survivors during the More Than Pink Walk in San Diego.
CooperSurgical participates at ASRM 2023 in New Orleans with live demonstrations, scientific presentations, and an exclusive sponsored symposium.
The Hologic Inc. vs Minerva Surgical patent infringement case is referenced again, this time in an article in IPWatchdog about Public-Use Bar.
August 2023
Commentary
In total, we had 31 (↑2) posts across LinkedIn, Facebook, Twitter and Instagram, in August.
- Impressions and Engagement Rate on Instagram nearly doubled (↑89% and ↑96% respectively), with the Progress Registry announcement being the most engaging post of the month across platforms (40% ER). Other top IG content included a video with Barbara Levy and a post promoting Managing Menorrhagia.
- Overall engagements by volume across platforms increased for the month (↑12%). On LinkedIn, the most engaging content was intern Juliana’s send-off post, and the top post on X featured Dr. Gerard Reilly promoting the Progress registry.
- We continue to see a low amount of activation on Facebook.
- While still a relatively new activation, we added 6 new podcast plays each to the New Advances in Endometrial Ablation and Management of Menorrhagia podcast episodes.
August Stats
- 4.1K impressions
- LI: 3.5k
- TW: 146
- FB: 87
- IG: 334
- 514 engagements
- 11.69% ER
- TW: 7.41%
- LI: 11.61%
- FB: 0.93%
- IG: 18.02%
- 728 Followers
Industry Highlights
The UK’s NHS performs its first successful womb transplant, but the healthcare system is criticized by journalists on X.
A study covered by The Guardian finds that menstrual discs may be better for heavy periods than pads or tampons.
Competitor Highlights
Hologic CEO Steve MacMillan speaks with the BBC’s Aaron Heslehurst to discuss his leadership at Hologic. The company’s Breast & Skeletal Health Innovation Center, currently under construction, reaches a new milestone after receiving its certificate of occupancy.
Minerva Surgical presents at the H.C. Wainwright 25th Annual Global Investment Conference.
The Hologic Inc. vs Minerva Surgical patent infringement case is featured in an article from the Cooley law firm.
July 2023
Commentary
In total, we had 29 (↓12) posts across LinkedIn, Facebook, and Instagram, in July. This large decrease is due to us leveraging less Instagram Stories and no posts on Twitter.
- Several primary metrics improved, including our total number of followers (↑7%), driven largely by LinkedIn (↑46). Our engagement rate also rose, suggesting users are finding our content interesting. - Monthly impressions on LinkedIn decreased as we had less posts during July. The top post on LinkedIn (11.4% ER) was an internal employee shoutout. - Instagram has the highest ER among our channels, with our top post of the month generating the highest engagement rate (20.83%).
- We continue to see a low amount of activation on Facebook.
July Stats
- 5.2k impressions
- LI: 4.9k
- TW: x
- FB: 119
- IG: 176
- 458 engagements
- 7.71% ER
- TW:xx
- LI: 8.6%
- FB: 2.08%
- IG: 9.15%
- 669 Followers
May 2023
Commentary
In total, we had 27 (↑10) posts across LinkedIn, Twitter, Facebook, and newly activated Instagram, in May.
- Several primary metrics improved, including our total number of followers (↑9.5%) and engagement rate (↑.76%).
- Monthly impressions on LinkedIn slowed (↓13%), but we gained 83 new LinkedIn followers in April. Our top post (18% ER) was about.
- Impressions greatly increased on Twitter (↑2x), with the same LinkedIn photo fromACSM2023 generating the highest engagement.
- Facebook performed poorly, but our activation on Instagram generated a 10% engagement rate—led by patient content.
May Stats
- 2.6k impressions
- LI: 1.9k
- TW: 405
- FB: 138
- IG: 101
- 288 engagements
- 8.41% ER
- TW: 8.38%
- LI: 12.38%
- FB: 2.93%
- IG: 10.2
- 553 Followers
April 2023
Commentary
In total, we had 17 (↓6) posts across LinkedIn, Twitter, and Facebook in April.
- Several primary metrics improved, including our total number of followers (↑19%) and engagements by volume (↑22%).
- Monthly impressions on LinkedIn slowed (↓18%), but we gained 80 new LinkedIn followers in April, and our engagement rate increased 3%—driven in part by a post from our annual planning meeting (22% ER).
- Impressions steadily increased on Twitter and Facebook (↑60% and ↑75%, respectively).
- **Clinical outcome data and resources for HCPs** performed well on Twitter, with an average 10% engagement rate.
- Educational video content for patients performed well on Facebook (8% ER).
April Stats
- 2.6k impressions
- LI: 2.2k
- TW: 134
- FB: 265
- 387 engagements
- 7.65% ER
- TW: 8.69%
- LI: 14.48%
- FB: 2.85%
- 505 Followers
March 2023
Commentary
In total, we had 23 (↑5) posts across LinkedIn, Twitter, and Facebook in March.
- Nearly all primary metrics improved month-over-month, including our total number of followers (↑8%), engagements by volume (↑3%), and engagement rate (↑.4%).
- While monthly impressions on LinkedIn decreased (↓12%), the **overall engagement rate on the platform improved (↑3%).**This was partly driven by the month’s best-performing post highlighting Dr. Amy Moon’s use of the Cerene Cryotherapy Device in her office — generating a 26% engagement rate
- Impressions increased significantly on Twitter and Facebook (↑60% and ↑75%, respectively).
- Patient success stories and endorsements from HCPs performed well on Twitter, with an average 13% engagement rate.
- Educational content and resourcesfor patients performed well on Facebook (21.5% engagement rate).
March Stats
- 3.1k impressions
- LI: 2.7k
- TW: 285
- FB: 163
- 315 engagements
- 9.01% ER
- TW: 7.42
- LI: 11.8%
- FB: 6.46
- 423 Followers
February 2023
Commentary
In total, we had 19 posts across LinkedIn, Twitter, and Facebook in February. * All metrics increased this month. The highest performing post in impressions and engagements was the Vail OB-GYN post on LinkedIn; the post drove 401 impressions and an engagement rate of 14.96%. * We saw solid growth MoM across our impressions, engagements, eng. rate, and followers. Educational content continued to perform well on Twitter. Real-time and Dr. testimonial content performed well on LinkedIn suggesting we should continue to post similar content on the respective platforms. * Engagement rate increase on both LinkedIn and Twitter, likely due to our growing audience.
February Stats
- 3.4k impressions
- LI: 3.1k
- TW: 178
- FB: 93
- 306 engagements
- 8.63% ER
- TW: 10.2
- LI: 8.95
- FB: 2.53
- 393 Followers
Other Info
Who are the top gynecologic surgeons on Twitter? Pulled on ChatGPT June 4, 2023
- Dr. Amanda Nickles Fader (@AmandaNFader) - Gynecologic oncologist and surgeon
- Dr. Shannon Westin (@ShannonWestin) - Gynecologic oncologist and surgeon
- Dr. Marcela G. del Carmen (@MarcelaGCarmen) - Gynecologic oncologist and surgeon
- Dr. Jubilee Brown (@JubileeBrownMD) - Gynecologic oncologist and surgeon
- Dr. Kathleen Schmeler (@KSchmeler) - Gynecologic oncologist and surgeon
- Dr. David Cohn (@DrDavidCohn) - Gynecologic oncologist and surgeon
- Dr. Matthew Powell (@DrMatthewPowell) - Gynecologic oncologist and surgeon
- Dr. Michael Frumovitz (@Frumovitz) - Gynecologic oncologist and surgeon
- Dr. Warner Huh (@WarnerHuh) - Gynecologic oncologist and surgeon
- Dr. Robert Coleman (@RobertColemanMD) - Gynecologic oncologist and surgeon